Definition of Clazakizumab. Meaning of Clazakizumab. Synonyms of Clazakizumab

Here you will find one or more explanations in English for the word Clazakizumab. Also in the bottom left of the page several parts of wikipedia pages related to the word Clazakizumab and, of course, Clazakizumab synonyms and on the right images related to the word Clazakizumab.

Definition of Clazakizumab

No result for Clazakizumab. Showing similar results...

Meaning of Clazakizumab from wikipedia

- Clazakizumab (formerly ALD518 and BMS-945429), an investigational drug, is an aglycosylated, humanized rabbit monoclonal antibody against interleukin-6...
- Several agents are in clinical trials: olokizumab (CDP6038) elsilimomab, clazakizumab (BMS-945429, ALD518), sirukumab (CNTO 136), levilimab (BCD-089), and...
- ASM8 IL-6 Agonists: Atexakin alfa Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab...
- Vitaeris, a biopharmaceutical company focused on the development of Clazakizumab as a potential treatment option for organ transplant recipients experiencing...
- ASM8 IL-6 Agonists: Atexakin alfa Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab...
- ASM8 IL-6 Agonists: Atexakin alfa Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab...
- solid tumors Cixutumumab mab human IGF-1 receptor (CD221) solid tumors Clazakizumab mab humanized IL-6 rheumatoid arthritis Clenoliximab mab chimeric CD4...
- ASM8 IL-6 Agonists: Atexakin alfa Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab...
- ASM8 IL-6 Agonists: Atexakin alfa Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab...
- ASM8 IL-6 Agonists: Atexakin alfa Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab...